- The Systematic Review of the Efficacy and Safety of Immune Checkpoint Inhibitor in Urological Cancers
-
Hwang GY, Choi SY, Chang IH
- KMID: 2457590
- Korean J Urol Oncol.
- 2019 Aug;17(2):75-80.
- doi: 10.22465/kjuo.2019.17.2.75
To systematically review relevant literature on efficacy and safety of immune checkpoint inhibitors (ICIs) in patients with advanced and metastatic urothelial cell cancer (UCC), renal cell cancer (RCC), and prostate... -
- CITED
-
- Close
- SHARE
-
- Close
- Laparoscopic Partial Adrenalectomy: Surgical Technique and Outcome
-
Ko OS, Kim JY, Kim HJ, Jeong YB
- KMID: 2457594
- Korean J Urol Oncol.
- 2019 Aug;17(2):103-109.
- doi: 10.22465/kjuo.2019.17.2.103
PURPOSE: To examine the perioperative surgical and long-term outcomes of laparoscopic partial adrenalectomy (LPA) by comparing the results of laparoscopic total adrenalectomy (LTA). MATERIALS AND METHODS: A total of 132 transperitoneal... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Molecular and Protein Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer
-
Kim WT, Yun SJ, Kim WJ
- KMID: 2457591
- Korean J Urol Oncol.
- 2019 Aug;17(2):81-87.
- doi: 10.22465/kjuo.2019.17.2.81
Bladder cancer (BC) is the most common urinary tract neoplasm through the world. Around 80% of BC patients present with nonmuscle invasive bladder cancer (NMIBC). Transurethral resection (TUR) of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Early Experiences with Nivolumab in Patients with Metastatic Renal Cell Carcinoma and Failed Target Therapy
-
Lee JH, Kang M, Chung JH, Sung HH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Park SH, Kim B, Kwon GY, Seo SI
- KMID: 2457593
- Korean J Urol Oncol.
- 2019 Aug;17(2):96-102.
- doi: 10.22465/kjuo.2019.17.2.96
PURPOSE: The efficacy of nivolumab in metastatic renal cell carcinoma (mRCC) has been proven. However, the nivolumab experience in Korean patients with mRCC is still poorly reported. We report initial... -
- CITED
-
- Close
- SHARE
-
- Close
- Bacillus Calmette-Guérin (BCG)-Cell Wall Skeleton as Immunotherapeutic Option for BCG-Refractory Superficial Bladder Cancer
-
Whang YM, Yoon DH, Hwang GY, Choi YW, Chang IH
- KMID: 2457592
- Korean J Urol Oncol.
- 2019 Aug;17(2):88-95.
- doi: 10.22465/kjuo.2019.17.2.88
Although intravesical instillation of Mycobacterium bovis bacillus Calmette-Guérin (BCG) is the most successful cancer immunotherapy for superficial bladder cancer, the serious side effects are frequently arisen by using live mycobacteria.... -
- CITED
-
- Close
- SHARE
-
- Close
- Machine Learning Approaches for the Prediction of Prostate Cancer according to Age and the Prostate-Specific Antigen Level
-
Lee J, Yang SW, Lee S, Hyon YK, Kim J, Jin L, Lee JY, Park JM, Ha T, Shin JH, Lim JS, Na YG, Song KH
- KMID: 2457595
- Korean J Urol Oncol.
- 2019 Aug;17(2):110-117.
- doi: 10.22465/kjuo.2019.17.2.110
PURPOSE: The aim of this study was to evaluate the applicability of machine learning methods that combine data on age and prostate-specific antigen (PSA) levels for predicting prostate cancer. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
